[Combined surgical & Bayer E 39 treatment of inoperable carcinoma of larynx].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007822:Laryngeal Neoplasms; D007830:Larynx
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; LARYNX/neoplasms
Die kombinierte Behandlung des inoperablen Larynxkarzinoms mit Operation und Bayer E 39.